Going by the video, if Anavex truly are on the right track there will be forces none too happy.
Seems to me a smart move to have just one arm of the P2/3 AD trial in the US and AD P2 in Sweden.
May well be no coincidence that AD P2 was in Australia.
We could speculate that the Rett orphan drug trial in the US is in part to fly under the big radar to perhaps achieve accelerated approval and leg up on the swamp.
Pretty convinced we won’t see AD kicked off before Rett readout.
Do you suppose that the FDA was told not to fund anymore time to Amyloid AD trials during recent budget cycle? Just a wild speculation on connecting the dots.